US Patent Issued to NURIX THERAPEUTICS on Dec. 2 for "3-substituted piperidine compounds for Cbl-b inhibition, and use thereof" (California Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,485,144, issued on Dec. 2, was assigned to NURIX THERAPEUTICS INC. (San Francisco).

"3-substituted piperidine compounds for Cbl-b inhibition, and use thereof" was invented by Arthur T. Sands (San Francisco), Neil F. Bence (San Francisco), Christoph W. Zapf (San Francisco), Frederick Cohen (San Francisco), Chenbo Wang (San Francisco), Thomas Cummins (San Francisco), Hiroko Tanaka (San Francisco), Hunter Shunatona (Oakland, Calif.), Mario Cardozo (San Francisco), Dahlia Weiss (San Mateo, Calif.) and Jennifa Gosling (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds, compositions, and methods for use in inhibiting the E3 enzyme Cbl-b in...